Selective expression of CD44, a putative prostate cancer stem cell marker, in neuroendocrine tumor cells of human prostate cancer-Reference-Cited by-同舟云学术

Selective expression of CD44, a putative prostate cancer stem cell marker, in neuroendocrine tumor cells of human prostate cancer

Published:2009-05-15 Issue:7 Volume:69 Page:787-798
ISSN:0270-4137
Container-title:The Prostate
language:en
Short-container-title:Prostate

Author:

Palapattu Ganesh S.,Wu Chengyu,Silvers Christopher R.,Martin Heather B.,Williams Karin,Salamone Linda,Bushnell Timothy,Huang Li-Shan,Yang Qi,Huang Jiaoti

Publisher

Wiley

Subject

Urology,Oncology

Reference53 articles.

1. Prostate cancer 2004: Insights from national disease registries;Cooperberg;Oncology (Williston Park),2004

2. Management of advanced/metastatic prostate cancer: 2000 update;Hussain;Oncology (Williston Park),2000

3. Cancer stem cells: An old idea-A paradigm shift;Wicha;Cancer Res,2006

4. The cancer stem cell hypothesis: A work in progress;Tan;Lab Invest,2006

5. Cancer stem cells;Jordan;N Engl J Med,2006

Cited by 98 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Pre-existing cell subpopulations in primary prostate cancer tumors display surface fingerprints of docetaxel-resistant cells;Cellular Oncology;2024-08-20

2. Prostate Cancer;Biomedical Aspects of Solid Cancers;2024

3. Role of cancer stem cells in prostate cancer therapy resistance;Therapy Resistance in Prostate Cancer;2024

4. Epigenetic regulation of androgen dependent and independent prostate cancer;Advances in Cancer Research;2024

5. Metronomic Administration of Topotecan Alone and in Combination with Docetaxel Inhibits Epithelial–mesenchymal Transition in Aggressive Variant Prostate Cancers;Cancer Research Communications;2023-07-19